November 12, 2021
PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
PAR-21-336 - Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
PAR-21-340 - Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
PAR-21-339 - Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
PAR-21-338 - Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
PAR-21-337 - Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
Notice of Change to Expansion of Eligibility of Optional Companion Applications for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-340 (RC2), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to alert potential applicants of a change to the Key Dates for the following Funding Opportunity Announcements (FOAs):
PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
PAR-21-336 - Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
PAR-21-340 - Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
PAR-21-339 - Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
PAR-21-338 - Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
PAR-21-337 - Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
The following changes to the Key Dates of the above FOAs have been made:
Currently Reads:
Part 1. Overview Information
Key Dates
Posted Date
July 30, 2021
Open Date (Earliest Submission Date)
December 26, 2021
Letter of Intent Due Date(s)
30 days before the application due date
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
January 26, 2022 |
January 26, 2022 |
Not Applicable |
June 2022 |
October 2022 |
December 2022 |
|
May 13, 2022 |
May 13, 2022 |
Not Applicable |
October 2022 |
January 2023 |
April 2023 |
|
September 16, 2022 |
September 16, 2022 |
Not Applicable |
March 2023 |
May 2023 |
July 2023 |
|
January 13, 2023 |
January 13, 2023 |
Not Applicable |
June 2023 |
October 2023 |
December 2023 |
|
May 12, 2023 |
May 12, 2023 |
Not Applicable |
October 2023 |
January 2024 |
April 2024 |
|
September 15, 2023 |
September 15, 2023 |
Not Applicable |
March 2024 |
May 2024 |
July 2024 |
|
January 12, 2024 |
January 12, 2024 |
Not Applicable |
June 2024 |
October 2024 |
December 2024 |
|
May 17, 2024 |
May 17, 2024 |
Not Applicable |
October 2024 |
January 2025 |
April 2025 |
|
September 13, 2024 |
September 13, 2024 |
Not Applicable |
March 2025 |
May 2025 |
July 2025 |
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
September 14, 2024
Due Dates for E.O. 12372
Not Applicable
Modified to Read (changes shown in bold italics and date omissions are reflected within the table):
Part 1. Overview Information
Key Dates
Posted Date
July 30, 2021
Open Date (Earliest Submission Date)
April 13, 2022
Letter of Intent Due Date(s)
30 days before the application due date
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
May 13, 2022 |
May 13, 2022 |
Not Applicable |
October 2022 |
January 2023 |
April 2023 |
|
September 16, 2022 |
September 16, 2022 |
Not Applicable |
March 2023 |
May 2023 |
July 2023 |
|
January 13, 2023 |
January 13, 2023 |
Not Applicable |
June 2023 |
October 2023 |
December 2023 |
|
May 12, 2023 |
May 12, 2023 |
Not Applicable |
October 2023 |
January 2024 |
April 2024 |
|
September 15, 2023 |
September 15, 2023 |
Not Applicable |
March 2024 |
May 2024 |
July 2024 |
|
January 12, 2024 |
January 12, 2024 |
Not Applicable |
June 2024 |
October 2024 |
December 2024 |
|
May 17, 2024 |
May 17, 2024 |
Not Applicable |
October 2024 |
January 2025 |
April 2025 |
|
September 13, 2024 |
September 13, 2024 |
Not Applicable |
March 2025 |
May 2025 |
July 2025 |
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
September 14, 2024
Due Dates for E.O. 12372
Not Applicable
All other aspects of these FOAs remain the same.
PAR-21-293 - UM1 Research Project with Complex Structure Cooperative Agreement
Erica Rosemond, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-594-8927
Email: [email protected]
PAR-21-336 - K12 Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
Mercedes Rubio, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-480-8957
Email: [email protected]
PAR-21-340 - RC2 Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Pablo Cure, M.D., M.P.H.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-2014
Email: [email protected]
PAR-21-339 - R25 Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
Jamie Doyle, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-402-0403
Email: [email protected]
PAR-21-338 - T32 Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
Mercedes Rubio, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-480-8957
Email: [email protected]
PAR-21-337 - T32 Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
Mercedes Rubio, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-480-8957
Email: [email protected]
and Human Services (HHS)
